Fmoc-cycloleucine

Catalog No. :
ACONCR703
CAS No. :
117322-30-2
Molecular Formula :
C21H21NO4
Molecular Weight :
351.40

IUPAC Name:1-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclopentane-1-carboxylic acid

Fmoc-cycloleucine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g97%$56.00Login to see priceIn stockInquiry
100g97%$223.00Login to see priceIn stockInquiry
500g97%$856.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameFmoc-cycloleucine
IUPAC Name1-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)cyclopentane-1-carboxylic acid
MDL No.MFCD01074696
Molecular FormulaC21H21NO4
Molecular Weight351.40
SMILESO=C(C1(NC(OCC2C3=C(C4=C2C=CC=C4)C=CC=C3)=O)CCCC1)O
InChI KeyIECZEINPZOFWNU-UHFFFAOYSA-N
SynonymFmoc-DL-cycloleucine | 1-(9H-Fluoren-9-ylmethoxycarbonylamino)-cyclopentane carboxylic acid | F0866 | N-Fmoc-1-amino-1-cyclopentanecarboxylic acid | N1-(9-Fluorenylmethyloxycarbonyl)amino-1-cyclopentane carboxylic acid (Fmoc-AC5C-OH) | 1-((((9H-fluoren-9-
CAS No.117322-30-2
PubChem CID978345

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACONCR703 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXBOS715 route compound structure diagram
    ACXBOS71552-52-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACONCR703 route product structure diagram
    ACONCR703117322-30-2 In Stock
Inquiry

2. ACONCR703 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXBOS715 route compound structure diagram
    ACXBOS71552-52-8 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACONCR703 route product structure diagram
    ACONCR703117322-30-2 In Stock
Inquiry

Comments (0)